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PS56.
Clinical Outcomes and Aortic Architectural Changes
following TEVAR for Chronic Type B Thoracic Aortic
Dissection
Iden D. Andacheh, Karen Kim, Rodney White, Carlos
Donayre, Joe Chauvupun. Surgery, Harbor-UCLA Medi-
cal Center, Los Angeles, CA
Objectives: Review patient outcomes and assess aor-
tic volumetric changes following TEVAR for patients
with complicated chronic type B thoracic aortic
dissection.
Methods: 60 consecutive patients were treated at a
single institution from 2002 to 2009. Indications included:
aneurysmal enlargement (n51), failure of medical man-
agement (n7), and perforation (n1). 3-D CT recon-
structions during patient follow-up were analyzed for
changes in aortic volume and diameter.
Results: TEVAR was successfully performed in 98% of
all patients. The 30-day mortality rate was 19%; six were
procedure-related and four were cardiac events. Post-op
complication rate was 5%; there was one stroke and one
patient with spinal cord ischemia. Seven patients (12%)
required secondary procedure; four for endoleak and three
for persistent distal perfusion.
Conclusions: TEVAR is being considered as an appro-
priate treatment for complicated chronic type B dissection.
Following TEVAR, aortic remodeling occurs with a pre-
dictable linear expansion of the true lumen and regression
of the false lumen. Any deviation from this model suggests
endoleak or persistent distal perfusion. Patient outcomes
from increasing infrarenal aortic diameter and volume need
further investigation.
Table 1. Aortic Dimensional Change From Pre-Op
Time from Intervention
1
Month
3
Months
6
Months
1
Year
Change in Maximal Aortic Diameter
(All patients) 5% 5% 2% 2%
Change in Maximal Infrarenal
Diameter (patients with
dissection below renal arteries) 5% 10% N/A 18%
Change in Maximal Infrarenal
Diameter (patients without
dissection below renal arteries) 0.7% 5% N/A 4%
Infrarenal Total Volume Change
(patients with dissection below
renal arteries) 9% 13% 20% 22%
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The Pathogenesis of Primary Aortoenteric Fistula after
EVAR
Mazin Foteh, Gregory A. Stanley, Sumona Smith, Billy
Kim, Damon Pierce, G. P. Clagett. University of Texas
Southwestern Medical Center, Dallas, TX
Objectives: Secondary aortoenteric fistula (AEF) is an
uncommon, but well described complication of open ab-
dominal aortic aneurysm (AAA) repair, occurring in up to
4% of patients undergoing this procedure. The incidence of
this complication after endovascular aneurysm repair
(EVAR) is less than 1%. Many etiologies of secondary AEF
after EVAR have been proposed including caudal graft
migration, structurally compromised grafts, mechanical
erosion, and complicated endoleaks leading to aneurysm
sac enlargement. Primary AEF after EVAR has not been
widely reported.We propose that hematogenous secondary
graft infection after EVAR is the mechanism for subsequent
primary AEF.
Methods: This study retrospectively reviewed the
charts of five patients presenting at our institution with
infected EVAR stent grafts and AEF. Demographic, labo-
ratory, imaging, and operative data were compiled for
evaluation.
Results: Five patients with a mean age of 69 years
(range 60-76) had computed tomographic evidence of
aortoduodenal fistula occurring a mean of 8.8 months
(range 4-15) after EVAR. All patients were found to have
infectious problems at or before presentation with AEF
including pneumonia, periodontal abscess, wound infec-
tion, ischemic colitis, diverticulitis, and inflammatory
bowel disease. Four patients underwent endograft explant
with neoaortoiliac system (NAIS) reconstruction and duo-
denal repair or resection; one patient refused surgery. At
operation, the aneurysm sac was markedly inflamed with
communication to the overlying duodenum without me-
chanical erosion of the EVAR device. Cultures of two
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explanted endografts revealed streptococcus viridans
infection.
Conclusions: This study presents five cases of EVAR
endograft infection from an infectious or inflammatory
condition, leading to AEF formation. This reinforces the
importance of aggressive surveillance and antibiotic pro-
phylaxis for dental and other invasive procedures to prevent
a potentially fatal complication after EVAR.
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Complex Aortic Endografting Requires a New Classi-
fication System: A Proposed New Zonal System
Dominic Simring, Jane E. Cross, Toby Richards, Obi Agu,
Peter Harris, Krassi Ivancev. Multidisciplinary Endovascu-
lar Team, University College Hospital, London, United
Kingdom
Objectives: Complex aortic endografting has emerged
as an alternative to open surgery for pararenal, suprarenal
and thoracoabdominal aneurysms. Definitions of these an-
eurysms vary and are often related to clamp placement.
With the emergence of complex endovascular options for
repair, defining aneurysm morphology based on clamp
placement is now obsolete and a new classification system
should be developed.
Methods: We propose division of the visceral segment
into zones based on the anatomy and location of the
endovascular “seal-zone”:
- Zone 0: below the lowest renal artery
- Zone 1: between renal arteries
- Zone 2: between the upper renal artery and SMA
- Zone 3: between the SMA and CA
- Zone 4: above the CA
We present the results of our case series of complex
endovascular repair based on the above classification.
Results: Between April 2008 and August 2010, 145
EVAR were performed at a regional centre in the UK. We
classified 84 aneurysms as Zone 0, 20 as Zone1/2, 25 as
Zone 3 and 16 as Zone 4. Mean operative times were 5.1,
6.9 and 8.6 hours for Zones 1-2, 3 and 4 respectively.Mean
number of target vessels were 1.75 for zone 1-2 aneurysms,
2.9 for zone 3 and 3.5 for zone 4 aneurysms. Target vessel
patency was 97% for Zone 1-2, 96% for Zone 3 and 89% for
Zone 4. Morbidity in Zone 1-2 was 35% compared to 48%
in Zone 3 and 38% in Zone 4. 30 day mortality was 0% in
Zone 1-2, 16% in Zone 3 and 13% in Zone 4.
Conclusions: Higher seal-zones reflect more complex
procedures with more visceral vessels involved and are
associated with longer operations, more morbidity and
mortality. The proposed seal-zone classification allows for
accurate and reproducible differentiation between aneu-
rysms requiring complex endovascular repair, replacing the
surgical clamp-based classification.
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A Retrospective Review of the Prevalence, Growth
Rate, and Treatment Outcomes of Aortoiliac Aneu-
rysms in Orthotopic Heart Transplant Recipients
Steven Farley, Peter F. Lawrence, William Quinones-Bal-
drich, Wesley Moore. University of California, Los Ange-
les, Los Angeles, CA
Objectives: To study the prevalence, growth rate, and
treatment outcomes of abdominal aortic(AAA) and ili-
ac(IA) aneurysms in adult orthotopic heart transplant
(OHT) recipients at a high-volume transplant center.
Methods:Over a 10-year period, adult OHT recipients
who underwent CT scanning pre and post-transplant were
evaluated for AAA and IA aneurysms.
Results: Of the 638 OHT patients, 319 underwent a
CT scan of the abdomen; 32 (10%) with aneurysms were
identified. Patients with ischemic cardiomyopathy (ICM),
who represent 41% of our OHT population, had a signifi-
cantly elevated prevalence (20%) of AAA/IA. The preva-
lence of aneurysm in the non-ICM patients was not ele-
vated when compared to the general population. The mean
AAA and IA diameters were 37  9 and 22  3 mm,
respectively. Serial imaging in 14 patients demonstrated an
infrarenal growth rate of 7 5mm/year. Seven aneurysms,
with a mean diameter of 52 5 mm, underwent repair; six
elective operations (3 endovascular, 3 open) resulted in no
mortality. One patient died after emergent operation for a
mycotic AAA.
Conclusions: This is the largest reported series and the
only using cross-sectional imaging for aortoiliac aneurysms
in OHT patients. We recommend aneurysm screening for
ICM patients prior to heart transplant. Aneurysm growth
rate is greater in transplant patients and surveillance is
indicated, even for small aneurysms. Elective repair resulted
in a similar morbidity and mortality to non-transplant
patients and we recommend managing these patients using
standard aortic aneurysm guidelines.
AAA/IA Incidence by Cardiomyopathy Type
and Location
Patients AI IR I SR
Total 32 (10%) 6 (2%) 19 (6%) 5 (2%) 2 (1%)
Ischemic
Cardiomyopathy 24 (20%) 6 (5%) 14 (12%) 4 (3%) 0
Non-ischemic
cardiomyopathy 8 (4%) 0 5 (3%) 1 (1%) 2 (1%)
AIaortoiliac, IRinfrarenal, Iiliac, SRsuprarenal
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